Suppr超能文献

《医疗保险获取与责任法案》2.0:你准备好迎接基于绩效的激励支付系统了吗?

MACRA 2.0: are you ready for MIPS?

作者信息

Hirsch Joshua A, Rosenkrantz Andrew B, Ansari Sameer A, Manchikanti Laxmaiah, Nicola Gregory N

机构信息

NeuroEndovascular Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Department of Radiology, New York University Langone Medical Center, New York, New York, USA.

出版信息

J Neurointerv Surg. 2017 Jul;9(7):714-716. doi: 10.1136/neurintsurg-2016-012845. Epub 2016 Nov 24.

Abstract

The annual cost of healthcare delivery in the USA now exceeds US$3 trillion. Fee for service methodology is often implicated as a cause of this exceedingly high figure. The Affordable Care Act created the Center for Medicare and Medicaid Innovation (CMMI) to pilot test value based alternative payments for reimbursing physician services. In 2015, the Medicare Access and CHIP Reauthorization Act (MACRA) was passed into law. MACRA has dramatic implications for all US based healthcare providers. MACRA permanently repealed the Medicare Sustainable Growth Rate so as to stabilize physician part B Medicare payments, consolidated pre-existing federal performance programs into the Merit based Incentive Payments System (MIPS), and legislatively mandated new approaches to paying clinicians. Neurointerventionalists will predominantly participate in MIPS. MIPS unifies, updates, and streamlines previously existing federal performance programs, thereby reducing onerous redundancies and overall administrative burden, while consolidating performance based payment adjustments. While MIPS may be perceived as a straightforward continuation of fee for service methodology with performance modifiers, MIPS is better viewed as a stepping stone toward eventually adopting alternative payment models in later years. In October 2016, the Centers for Medicare and Medicaid Services (CMS) released a final rule for MACRA implementation, providing greater clarity regarding 2017 requirements. The final rule provides a range of options for easing MIPS reporting requirements in the first performance year. Nonetheless, taking the newly offered 'minimum possible' approach toward meeting the requirements will still have negative consequences for providers.

摘要

美国每年的医疗保健支出现已超过3万亿美元。按服务收费方法常被认为是造成这一极高数字的一个原因。《平价医疗法案》设立了医疗保险和医疗补助创新中心(CMMI),以试点测试基于价值的替代支付方式来报销医生服务费用。2015年,《医疗保险准入与儿童健康保险计划再授权法案》(MACRA)成为法律。MACRA对所有美国医疗服务提供者都有重大影响。MACRA永久废除了医疗保险可持续增长率,以稳定医生的医疗保险B部分支付,将先前存在的联邦绩效计划整合到基于绩效的激励支付系统(MIPS)中,并通过立法规定了支付临床医生的新方法。神经介入医生将主要参与MIPS。MIPS统一、更新并简化了先前存在的联邦绩效计划,从而减少了繁重的冗余和总体行政负担,同时整合了基于绩效的支付调整。虽然MIPS可能被视为带有绩效调整因素的按服务收费方法的直接延续,但MIPS更应被视为在未来几年最终采用替代支付模式的一块垫脚石。2016年10月,医疗保险和医疗补助服务中心(CMS)发布了MACRA实施的最终规则,对2017年的要求提供了更清晰的说明。最终规则为在首个绩效年度放宽MIPS报告要求提供了一系列选择。尽管如此,采取新提出的“尽可能最低限度”的方法来满足要求仍将给提供者带来负面影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验